Our results agree with studies demonstrating that STING stimulation leads to increased immune cell activation and tumor cell targeting (66), suggesting that STING agonist treatment in addition to conventional therapies would have a positive impact on antitumor immune responses in HNSCCs. Here, STING1 is linked to neoplasm.